PubMed · 10857109
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A Orren. 2000. Screening for complement deficiency.. https://doi.org/10.1385/1-59259-056-x%3A139
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Diabetes is characterized by impaired fibrinolysis. This phenomenon reflects augmented concentrations of plasminogen activator inhibitor type-1 in tissues and in blood. The derangement appears to depend in part on elevated concentrations of free fatty acids, triglycerides, and insulin in association with the insulin resistance syndrome. Impaired fibrinolysis may exacerbate already existing coronary artery disease and potentiate its evolution. Several measures are available to favorably modify fibrinolytic system capacity. They include inhibition of the renin angiotensin system, attenuation of dyslipidemia, and enhancement of insulin sensitivity. Accordingly, normalization of the derangement in fibrinolysis typical of diabetes is an important and achievable therapeutic objective.
Explore the source record for details and available documents.
Explore the source record for details and available documents.